diphenyleneiodonium has been researched along with Diabetes Mellitus in 2 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Weaver, JR | 1 |
Holman, TR | 1 |
Imai, Y | 1 |
Jadhav, A | 1 |
Kenyon, V | 1 |
Maloney, DJ | 1 |
Nadler, JL | 1 |
Rai, G | 1 |
Simeonov, A | 1 |
Taylor-Fishwick, DA | 1 |
Ye, G | 1 |
Metreveli, NS | 1 |
Ren, J | 1 |
Epstein, PN | 1 |
2 other studies available for diphenyleneiodonium and Diabetes Mellitus
Article | Year |
---|---|
Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction.
Topics: Acetophenones; Animals; Apoptosis; Arachidonate 12-Lipoxygenase; Caspase 3; Chemokine CCL2; Diabetes | 2012 |
Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Diabetes Complications; Diabetes | 2003 |